Ignite Creation Date:
2025-12-25 @ 3:08 AM
Ignite Modification Date:
2026-05-09 @ 3:13 PM
Study NCT ID:
NCT00510133
Status:
COMPLETED
Last Update Posted:
2019-07-09
First Post:
2007-07-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML)
Sponsor:
Asterias Biotherapeutics, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GRNVAC1 CP06-151
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None